Longitudinal Advanced Prostate Cancer Cohort (LAPCC)

Recruiting now

Conditions studied: Prostate Carcinoma

In brief

This study examines information from patients with prostate cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). By collecting biological samples (like blood, urine, and tissue), and health information (such as treatment, diet, and quality of life) researchers hope to learn more about prostate cancer and ways to improve outcomes in the future.

Key facts

Study ID

NCT06067295

Run by

University of Southern California

People needed

300

Starts

2023-02-21

Expected to finish

2027-12-31

Last updated by the study team

2026-03-10

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Men of all racial and ethnic groups 18 years of age or older
• Men with a diagnosis of advanced (metastatic) prostate cancer who are scheduled to begin a new systemic treatment (including first or subsequent lines of therapy)
• Prior participation on clinical trials is allowed

You may not qualify if…

• Inability to give informed consent
• Any other malignancy, unless previously treated with curative intent and the subject has been disease free for 3 years or longer

Where it is running

• Los Angeles General Medical Center — Los Angeles, California, United States (enrolling)
• USC / Norris Comprehensive Cancer Center — Los Angeles, California, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.